Life Science Washington
Life Science Washington is the trade association for Washington state's life science companies and organizations.
Facts
- HQ
- Seattle
- Sectors
- Industry Associations
- Founded
- 1989
- Employees
- 32
Is this your organization? Claim it
Talus Bioscience launches Ptarmigan-1, structure-free AI that predicts binding sites across human proteome
Talus Bioscience has launched Ptarmigan-1, a structure-free AI model that predicts small-molecule binding sites across the entire human proteome, including highly unstructured proteins. The model, built on Talus’s MARMOT platform, is accessible now via a public portal.
Xaira Therapeutics Unveils X-Design Generative AI to Design Drug-Ready Antibodies and Details Early Pipeline
Xaira Therapeutics unveiled X-Design, its generative AI platform for designing drug-ready antibodies, and disclosed initial details about its therapeutic pipeline and companion models X-Cell and X-Patient.
Life Science Washington, Arzeda Host NSCEB Commissioners in Seattle to Press for $15B Federal Boost and Policy Changes to Shore Up U.S. Biotech Competitiveness
Life Science Washington and Arzeda hosted NSCEB commissioners in Seattle to showcase the region’s biotech strengths and discuss federal policy, emphasizing needs for research funding, capital access, scale-up capacity, AI-enabled infrastructure, and workforce development to bolster U.S. biotech competitiveness against China.
Jessica Kamada’s Swizzle Ventures Deploys Inaugural Fund to Back ~30 Women’s Health and Wealth Startups, Already Invested in 10
Jessica Kamada founded Swizzle Ventures and is using its first fund to back about 30 startups targeting women’s health and wealth, already investing in 10 companies including Trellis Health, Mavida Health, and Alinea.
Eric Larsen, Innovation Fund Manager at Alliance of Angels, former Quellos/BlackRock leader who built Quasar and expanded it into Aladdin CRM used by 5,000+ employees
Eric Larsen is an investor and Innovation Fund Manager at Alliance of Angels who advises startups, co-heads the Life Sciences Screening Committee, and has led multiple fundraising rounds using expertise in engineering, technology, finance, and operations.
Will Canestaro, PhD — VC and Health Economist Managing Foundation’s Biotech & Engineering Portfolio with 25 Investments in 19 Washington Companies
Will Canestaro, PhD, is a venture capitalist, health economist, and meta-epidemiologist who manages a foundation’s biotech and engineering VC portfolio, has made 25 investments in 19 Washington companies, and teaches health innovation and meta-analytic methods at the University of Washington; he holds a PhD from UW, an M.Sc. from Oxford, and an A.B. from Dartmouth.
Allen Nieman: Investor and Fund Manager Who Guided SAC Health Startups to Convertible-Note Conversions and Series A Raises
Allen Nieman is an investor and fund manager involved with groups like Seattle Angel Conference, Apis Health Angel, and Grubstakes, and has overseen SAC health companies through convertible note conversions and Series A raises. He previously held product and marketing executive roles with full P&L responsibility in B2C and B2B software, participated in M&A on both buy and sell sides, and is a US Marine Corps veteran.
People
-
Marc Cummings Executive, President & CEO